Rivastigmine helps patients with brain injuries

Traumatic brain injuries are among the most common serious brain disorders in the US.

More than 5 million Americans are living with a disability like memory loss, suffered after a brain injury.

In one study, the alzheimer's drug, Rivastigmine, helped 30 percent of patients recall additional words on a test.

That was compared to ten percent on a placebo.

The drug enhances a chemical involved in memory and learning. "They can focus their attention better. They can concentrate better. They can recall things more easily," says Dr. Douglas Katz of Boston University.

Ryevastigmeen is FDA approved to treat alzheimer's.

The drug will undergo more studies before it can be approved to treat memory loss.

The drug does not need to be given immediately after the accident

WNDU - Channel 16 54516 State Road 933 South Bend, IN 46637 Front Desk: 574-284-3000 Newsroom: 574-284-3016 Email: newscenter16@wndu.com
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 5146722 - wndu.com/a?a=5146722
Gray Television, Inc.